HOME >> BIOLOGY >> NEWS
Turning viruses into allies against cancer

Anaheim, Calif. -- To most, the mere mention of the word "virus" stirs up memories of pain, fever and varying levels of suffering. But in recent years, scientists have been trying to turn these long-time medical foes into allies in the fight against cancer.

Through genetic engineering, viruses are being re-programmed to take advantage of their natural abilities to infiltrate, commandeer, replicate and destroy, but only in tumor cells and not surrounding healthy tissue.

Several of these "oncolytic" (cancer-killing) viruses are in varying stages of development, including modifications of the virus that causes measles and another, the herpes simplex virus, responsible for those lip blisters known as cold sores.

In studies presented this week at the 96th meeting of the American Association for Cancer Research (AACR), researchers describe their latest studies with their engineered versions of these viruses.

Cold Sore Virus Modified to Halt Growth and Spread of a Variety of Tumors: Abstract 5292

A modified herpes simplex virus, built with a potent immune stimulant to thwart the spread of cancer cells, is being tested in patients with a variety of tumor types, including melanoma, breast, head and neck, and colorectal cancer.

In early clinical studies, the engineered virus -- developed by Biovex Ltd. under the trade name OncoVEX -- showed promise of causing necrosis (death) of tumors cells in most patients.

"Tumor necrosis was evidenced clinically and/or by histology in biopsies taken about two weeks after the final dose in a number of patients," said Jennifer Hu, M.B.B.S., a clinical research fellow at Hammersmith Hospital (Imperial College) in London, who conducted much of the study. "In some cases necrosis was considerable."

Like other oncolytic viruses, the modified herpes simplex virus used in these studies was engineered to attack tumors cells without harming surrounding healthy tissue. This virus also wa
'"/>

Contact: Warren R. Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
19-Apr-2005


Page: 1 2 3 4

Related biology news :

1. Turning the tables in chemistry
2. Turning a cellular sentinel into a cancer killer
3. Turning green into yellow
4. Turning sensation into perception
5. Features of replication suggest viruses have common themes, vulnerabilities
6. Discovery in plant virus may help prevent HIV and similar viruses
7. MIT, BU team builds viruses to combat harmful biofilms
8. Revealed -- Mosquito genes that could be controlling the spread of killer viruses
9. How memory T cells curb the spread of viruses throughout the body
10. Insignia -- A new way to identify viruses and bacteria
11. Spreading viruses as we breathe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... ... Greffex, a pioneering vaccine and gene therapy company based in Houston, Texas, welcomes ... a global perspective to make an impact in a post pandemic world,” said Co-Chairman ... independent, director of the company. , “The Greffex board is excited to have Neil ...
(Date:5/30/2020)... ... May 29, 2020 , ... eInfochips, a leading provider of ... with EchoNous Inc. to develop the cloud-based connected health KOSMOS platform that has ... has been clinically tested versus expert measurements, yielding improved results in precision and ...
(Date:5/28/2020)... (PRWEB) , ... May 27, 2020 , ... ... hc1 Workforce Advisor™ , a solution that uniquely combines lab testing insights ... help employers systematically support the ongoing health and safety of employees returning to ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... ... that the launch of a new clinical diagnostics immuno-oncology service, TissueInsight ... microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, ...
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
(Date:6/19/2020)... ... , ... The Vitaspace project was founded by the famous Russian ... life and find a way (medicine or technology) that will help to preserve youth, ... scientists from all over the world, doctors, and all people who care. , The ...
(Date:6/3/2020)... MONTREAL (PRWEB) , ... June 03, 2020 , ... ... designed to highlight various applications of biofeedback. In the next installment, Dr. Inna ... a practice whereby individuals learn to bring their attention to the feelings, thoughts, ...
Breaking Biology Technology:
Cached News: